This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Chronic Allograft Nephropathy
and you are
between 20 and 50
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to evaluate the effect of Prostaglandin I2 analogue use on the development of chronic allograft nephropathy and changes in allograft function in prevalent renal transplant recipients

Provided treatments

  • Drug: prostaglandin I2 analogue

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01056835. The sponsor of the trial is Seoul National University Hospital and it is looking for 40 volunteers for the current phase.
Official trial title:
Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy